Australia markets close in 3 hours 36 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.44-0.43 (-3.62%)
At close: 04:00PM EDT
11.40 -0.04 (-0.35%)
After hours: 06:04PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2021
30/09/2020
30/09/2019
30/09/2018
Cash flows from operating activities
Net income
-45,406
-37,909
-26,280
-26,295
-17,453
Depreciation & amortisation
-
-
-
-
0
Stock-based compensation
15,489
8,231
4,877
6,431
5,517
Change in working capital
2,048
-706.443
116.518
1,302
-646.001
Accounts payable
-1,050
750.727
465.722
683.797
-
Other working capital
-27,868
-30,384
-21,287
-18,527
-12,582
Other non-cash items
-
-
-
35.375
-
Net cash provided by operating activities
-27,868
-30,384
-21,287
-18,527
-12,582
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
20,982
153,219
28,754
17,832
8,174
Other financing activities
-724.262
-5,551
-403.764
-50
-101.133
Net cash used provided by (used for) financing activities
23,508
153,242
28,350
17,782
8,073
Net change in cash
-4,361
122,859
7,063
-745.008
-4,510
Cash at beginning of period
157,560
29,249
22,186
22,931
27,440
Cash at end of period
153,199
152,108
29,249
22,186
22,931
Free cash flow
Operating cash flow
-27,868
-30,384
-21,287
-18,527
-12,582
Free cash flow
-27,868
-30,384
-21,287
-18,527
-12,582